BRUSSELS SOUTH CHARLEROIBIOPARK

THE SCIENCE-DRIVEN BIOPARK AT THE HEART OF EUROPE

500 M€

YEARLY BIOTECH DEAL FLOW

Biopark

2000

HIGHLY SKILLED PEOPLE

Biopark

60

LIFE SCIENCE COMPANIES

Biopark

15

CLINICAL TRIALS SITES

Biopark

6

TECHNOLOGY PLATFORMS

Biopark

3

CROSS-FACULTY RESEARCH INSTITUTES

Biopark

MORE THAN 2,000 HIGHLY SKILLED PEOPLE FROM MORE THAN 30 COUNTRIES

OUR MISSION IS TO SUPPORT COMPANY GROWTH FROM INNOVATIVE START-UPS THROUGH TO GLOBAL PLAYERS

BIOPARK SKY VIEW

Testimonials

TESTIMONIALS

GREAT PLACE TO WORK

GREAT PLACE TO INVEST

GREAT PLACE TO GROW

MARGREET BROUWERSENIOR RESEARCH ASSISTANT AT Iteos Therapeutics

Testimonials

"As a former Research Assistant at ULB and now part of iTeos’ team, a biotech company headquartered here, I am delighted to see that the BioPark has attracted so many companies and people active in the life sciences sector and that it has evolved into a dynamic working environment with excellent amenities and social activities. The park’s unique cluster reinforces collaborations, stimulates knowledge sharing and creativity."

— Margreet Brouwer, Senior Research Assistant, Iteos Therapeutics

CHRIS BUYSEMANAGING PARTNER AT Fund+

Testimonials

"The BioPark’s cluster of innovative life sciences companies and their talented, multilingual and diverse work force together with the park’s state-of-the-art facilities make it an attractive place to invest. It provides an unique ecosystem of scientific, clinical and business expertise to progress early stage research and drug development through to stages offering excellent returns on investment with remarkable impact on society.”

— Chris Buyse, Managing Partner, Fund+

DENIS BEDORET PRESIDENT AT MaSTherCell Global

Testimonials

"The BioPark’s unique focus and expertise provide the perfect environment to grow your business into a fully-fledged, global company. The hands-on support we have received from the team, along with access to the BioPark’s outstanding services, have been a great help in establishing MTC as a distinguished, international cell therapy manufacturing company.”

— Denis Bedoret, President, MaSTherCell Global

WANT TO RECEIVE OUR MONTHLY NEWSLETTER?

NEWS

December 16th 2019

Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D. Total amount raised in the Series D reaches €47.2 Million.Promethera® Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced the addition of €7.5 million to its recent €39.7 million Series D financing led...

News

December 13th 2019

Belgium - an innovative pharma valley in EuropeBelgium holds a leading position in the European (bio)pharmaceutical sector. Among all countries of the European Union, Belgium has the highest level of pharmaceutical investments in research and deve...

News

EVENTS

January 16th 2020

ANCHORING CLINICAL RESEARCH IN BELGIUMClinical research also refers to a multistakeholder landscape in which tracing its path can be a challenging task, in particular for SMEs willing to bring their health innovations ultimately to the pa...

16.01.2020 / 9:00 > 6:30 PM Square Brussels Convention Center - Mont des Arts, 1000 Bruxelles

Events

January 24th 2020

BioPark SeminarJulie Déchanet-Merville, University of Bordeaux. « To be announced » Invited by David Vermijlen, PhD, Department of Pharmacotherapy and Pharmaceutics - Institute for Medical I...

24.01.2020 / 11:30 > 12:30 PM BIOPOLE-IMI, Salle détente / Rue Adrienne Bolland 8, 6041 GOSSELIES

Events